Category: Peds News

UNC researchers have received ~$7.3M from NHLBI to lead the Rare Bronchiectatic Diseases Consortium, advancing research on four rare lung diseases that cause progressive bronchiectasis. The effort builds on UNC’s national leadership and aims to accelerate discovery, clinical trials, and new therapies for underserved patient populations.

Amy Levenson, MD, Professor of Pediatrics in the Division of Endocrinology and Vice Chair of Education, has been selected by the American Pediatric Association to join the National Academy of Distinguished Educators in Pediatrics (NADEP) as a member of its third cohort.

Elizabeth Corteselli used an NC TraCS pilot grant to create a new model for studying lung diseases and potential treatments. Only a few medications are currently approved to treat idiopathic pulmonary fibrosis (IPF) in the U.S., and these can sometimes cause significant side effects. Elizabeth Corteselli, a pediatric allergy and...

Dr. Dosier joined the Department of Pediatrics as an Associate Professor in the division of Pediatric Pulmonology on January 20, 2026. Dr. Dosier received her BS in 2005 from the University of Southern California, and earned her medical degree from the University of North Carolina at Chapel Hill in 2010....

BRAINY-T1D is a nationwide effort aimed at understanding the earliest effects of Type 1 Diabetes in young children. UNC is one of eleven campuses participating in this NIH project. At UNC, the study is led by an interdisciplinary group of investigators whose expertise spans neuroimaging, endocrinology, pediatrics, occupational therapy and...

UNC School of Medicine Office of Research awards pilot funding to Moran and Kulis team for cutting-edge New Approach Methodologies research.

Zina McSweeney, DO joined the Pediatric Division of Endocrinology on January 5, 2026 as a part-time Assistant Professor. Dr. McSweeney received her Bachelor of Biomedical Science in 2015 from the University of Central Florida and then earned her DO from Campbell University in 2019. She completed her Pediatric Internship and...

Joseph Muenzer, MD, PhD, leads research on groundbreaking therapy that offers hope for patients across the world living with a devastating genetic disorder. Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ultra-rare disorder that causes progressive multisystem disease and neurologic decline.

UNC has been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to implement research findings on early childhood obesity prevention. The project is co-led by Dual Principal Investigators Dr. Kori Flower in the UNC Department of Pediatrics and Dr. Eliana Perrin at The Johns Hopkins University.

The Center for Molecular Medicine (CMM), formerly the UNC Gene Therapy Center, launched a new effort to give potential Einsteins a foot in the door. The newly revamped Center, located in the Thurston Bowles Building, is buzzing with undergraduates and high school students looking to get a head start on...